Continuous hemodiafiltration using PMMA membrane: Clinical efficacy and its mechanisms

Contributions to Nephrology

Volumn 125, Issue , 1999, Pages 222-232

  Moriyama, Kazuhiro ^a   Soejima, Yoshiyuki ^b  

^a TORAY INDUSTRIES INC   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR; BIOMATERIAL; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN; POLY(METHYL METHACRYLATE);

ARTIFICIAL MEMBRANE; BIOSYNTHESIS; BLOOD; CELL LINE; CHRONIC KIDNEY FAILURE; CYTOLOGY; HEMODIAFILTRATION; HUMAN; INFECTION; INFLAMMATION; INSTRUMENTATION; JAPAN; METABOLIC CLEARANCE RATE; METABOLISM; MOLECULAR WEIGHT; MULTIPLE ORGAN FAILURE; REVIEW; VASCULAR ENDOTHELIUM;

BIOCOMPATIBLE MATERIALS; BIOLOGICAL FACTORS; CELL LINE; CYTOKINES; ENDOTHELIUM, VASCULAR; HEMODIAFILTRATION; HUMANS; INFECTION; INFLAMMATION; JAPAN; KIDNEY FAILURE, CHRONIC; MEMBRANES, ARTIFICIAL; METABOLIC CLEARANCE RATE; MOLECULAR WEIGHT; MULTIPLE ORGAN FAILURE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; POLYMETHYL METHACRYLATE;

EID: 0032608486     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (21)

1. Hirasawa H, Sugai T, Ohtake Y: Continuous hemofiltration and hemofiltration in the management of multiple organ failure. Contrib Nephrol. Basel, Karger, 1991, vol 93, pp 42-46.
2. Biffl WL, Moore FA, Barnett CC Jr: Interleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor. J Trauma 1996;40:575-578.
3. Bellomo R: Continuous hemofiltration as blood purification in sepsis. New Horiz 1995;3:732-737.
4. Hirasawa H, Sugai T, Ohtake Y: Blood purification for prevention and treatment of multiple organ failure. World J Surg 1996;20:482-486.
5. Hamada Y, Kishi H, Hotta O: Efficiency of cytokine elimination with CHDF using PMMA membrane (in Japanese). Intensive Crit Care Med (Japan) 1997;9:229-233.
6. Kitano T, Hattori S, Yoshitake S: Time course of IL-8 and ICAM-1 elimination with continuous hemodiafiltration in postsurgical acute renal failure patients (abstract). 7th World Congress of Intensive and Critical Care Medicine, Ottawa 1997, p 97.
7. Amore A, Bonaudo R, Ghigo D: Enhanced production of nitric oxide by blood-dialysis membrane interaction. J Am Soc Nephrol 1995;6:1278-1283.
8. Matheson NR, Wong PS, Travis J: Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem Biophys Res Commun 1979;88:402-409.
9. Tsubo T, Araki K, Kitayama M: Effect of continuous hemodiafiltration on IL-6 and granulocyte elastase elimination. Jpn J Artif Organs 1997;26:943-945.
10. Hakim RM, Wingard RL, Parker RA: Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994;331:1338-1342.
11. Kitamura N, Hirasawa H, Sugai T: Indication and efficacy of blood purification in the treatment of multiple organ failure. Jpn J Apheresis 1995;14:38-40.
12. Pascual M, Schifferli JA, Pannatier JG: Removal of complement factor D by absorption on polymethylmethacrylate dialysis membranes. Nephrol Dial Transplant 1993;8:1305-1311.
13. Ogawa M: Mechanisms of the development of organ failure following surgical insult - The 'second attack' theory. Clin Intensive Care 1996;7:34-38.
14. Shoji H, Tani T, Hanazawa K: Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: Designing and antiendotoxin efficacy in the clinical application. Ther Apheresis 1998;2:3-12.
15. Kodama M, Tani T, Hanasawa K: Treatment of sepsis by plasma endotoxin removal: Hemoperfusion using a polymyxin-B immobilized column. J Endotoxin Res 1997;4:293-300.
16. Kodama M, Tani T, Hanazawa K: Extracorporeal removal of results in the septic patients by Toraymyxin - Clinical results in a phase II and III in Japan (abstract). Shock 1997;7 (suppl):6.
17. van Bommel EFH, Hesse CJ, Jutte NHPM: Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering form systemic inflammatory response syndrome. Ren Fail 1997;19:443-454.
18. van Bommel EFH, Hesse CJ, Juttte NHPM: Cytokine kinetics (TNF-α, IL-1β, IL-6) during continuous hemofiltration: A laboratory and clinical study. Contrib Nephrol. Basel, Karger, 1995, vol 116, pp 62-75.
19. Bellomo R, Tipping P, Boyce N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993;21:522-526.
20. Bellomo R, Tipping P, Boyce N: Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Ren Fail 1995;17:457-466.
21. Heering P, Morgera S, Schmitz FJ: Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1997;23:288-296.